The controversy over "counterfeit" drugs

LONDON 02 October 2013 (IRIN) – One of the biggest hurdles to stemming the global tide of counterfeit medicines is disagreement over the term itself, which drug companies are accused of hijacking for commercial rather than public health reasons.

Powered by WPeMatico

This entry was posted in Science. Bookmark the permalink.

Comments are closed.